Home » Topics » Regulatory » Patents

Patents
RSS

Mission Therapeutics synthesizes USP30 inhibitors

Jan. 3, 2022

Roche presents compounds for Gram-negative bacterial infections

Jan. 3, 2022

Betta Pharmaceuticals divulges new PTPN11 inhibitors

Jan. 3, 2022

Chinese researchers disclose SOS1 inhibitors

Jan. 3, 2022

Medshine Discovery patents new GLP-1 receptor agonists

Jan. 3, 2022

New PD-1/PD-L1 interaction inhibitors identified at Kainos Medicine

Dec. 31, 2021

Kinnate Biopharma discovers FGFR inhibitors

Dec. 31, 2021

CSPC Zhongqi Pharmaceutical Technology patents PTPN11 inhibitors

Dec. 31, 2021

New CDK7 inhibitors presented by ScinnoHub Pharmaceutical

Dec. 31, 2021

Medshine Discovery identifies new NLRP3 inflammasome inhibitors

Dec. 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...